Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10020175HBVENSG00000111816.8protein_codingFRKNoNo2444P42685
TVIS20045193HPVENSG00000111816.8protein_codingFRKNoNo2444P42685
TVIS20061030HPVENSG00000111816.8protein_codingFRKNoNo2444P42685
TVIS20060988HPVENSG00000111816.8protein_codingFRKNoNo2444P42685
TVIS20064809HPVENSG00000111816.8protein_codingFRKNoNo2444P42685
TVIS20034880HPVENSG00000111816.8protein_codingFRKNoNo2444P42685
TCGA Plot Options
Drug Information
GeneFRK
DrugBank IDDB01254
Drug NameDasatinib
Target IDBE0004742
UniProt IDP42685
Regulation Typebinder
PubMed IDs18180381
CitationsKneidinger M, Schmidt U, Rix U, Gleixner KV, Vales A, Baumgartner C, Lupinek C, Weghofer M, Bennett KL, Herrmann H, Schebesta A, Thomas WR, Vrtala S, Valenta R, Lee FY, Ellmeier W, Superti-Furga G, Valent P: The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood. 2008 Mar 15;111(6):3097-107. doi: 10.1182/blood-2007-08-104372. Epub 2008 Jan 7.
GroupsApproved; Investigational
Direct ClassificationAromatic anilides
SMILESCC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
PathwaysDasatinib Inhibition of BCR-ABL
PharmGKBPA162372878
ChEMBLCHEMBL1421